We are live on ! Find out more
TGI

TRV GP IV Portfolio holdings

AUM $267M
1-Year Est. Return 965.83%
This Fund
S&P 500
This Quarter Est. Return
+54.02%
1 Year Est. Return
+965.83%
3 Year Est. Return
+686.22%
5 Year Est. Return
+581.56%
10 Year Est. Return
AUM
$267M
AUM Growth
+$11.8M
Cap. Flow
-$20.9M
Cap. Flow %
-7.82%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TNGX icon
Tango Therapeutics
TNGX
+$20.9M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAZE
1
Maze Therapeutics
MAZE
$1.49B
$134M 50.04%
4,473,958
TNGX icon
2
Tango Therapeutics
TNGX
$4.43B
$133M 49.96%
6,374,574
-1,500,000
-19% -$20.9M

Similar funds

TRV GP IV's Q1 2026 Portfolio in Review

As of Q1 2026, TRV GP IV held 2 positions worth $267M, up 4.6% from $255M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

TRV GP IV withdrew a net $20.9M in Q1 2026, reducing 1 holding. Its largest reduction was Tango Therapeutics, cutting an estimated $20.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP IV's biggest Q1 2026 reduction was Tango Therapeutics, cutting an estimated $20.9M.
  • TRV GP IV's ten largest holdings make up 100% of its $267M portfolio in Q1 2026.
  • TRV GP IV opened 0 new positions and closed 0 in Q1 2026.
  • TRV GP IV's portfolio value rose 4.6% quarter-over-quarter to $267M.

Based on TRV GP IV's 13F filing for Q1 2026, filed 7 May 2026.